Exclusive

Publication

Byline

Japan's Shionogi transfers generic drug business to Zhejiang Gaozhi Pharma in China

Singapore, Nov. 3 -- Japan-based pharma firm Shionogi has announced that Shionogi China, a Shionogi group company in China, has entered into a share transfer agreement with Zhejiang Gaozhi Pharmaceuti... Read More


Cambrex breaks ground on $120 M expansion in US for pharma CDMO capabilities

Singapore, Nov. 3 -- Cambrex, a leading global contract development and manufacturing organisation (CDMO), has marked the groundbreaking of its $120 million expansion at its Charles City, Iowa facilit... Read More


QIAGEN supports Singapore's National Precision Medicine programme with sample prep and next-gen sequencing technologies

Singapore, Nov. 3 -- QIAGEN has announced that its QIAsprint Connect and QIAseq FX DNA Library Kit will support automated DNA extraction and library preparation for the SG-INSIGHT study, a cohort unde... Read More


India-based Taisho Ventures receives Rs 7.4 Cr from DBS Foundation to advance active ageing

Singapore, Nov. 3 -- DBS Foundation has announced SGD 3 million (approximately Rs 22 crore) in funding for four purpose-driven businesses across Asia, including India's Taisho Ventures (Khyaal), which... Read More


Illumina selected to help bring precision medicine into everyday healthcare in Singapore

Singapore, Nov. 3 -- Illumina has announced it has been selected to provide whole-genome sequencing services for the SG-INSIGHT study, a cohort under Phase III of Singapore's National Precision Medici... Read More


Merck opens €300 M Asia-Pacific bioprocessing centre in Daejeon, South Korea

Singapore, Nov. 2 -- Merck, a leading science and technology company, has opened its new Asia-Pacific Bioprocessing Production Centre in Daejeon, South Korea. The centre represents an investment of mo... Read More


Singapore study highlights hidden recurrence risk in node-negative early breast cancer patients

Singapore, Nov. 2 -- A new Singapore study found that around one in six (16.7%) higher-risk patients with hormone receptor-positive (HR+), HER2-negative early breast cancer whose cancer had not spread... Read More


BioMarin signs deal worth $475 M with Korea's GC Biopharma and Hanmi Pharm for potential treatment of Fabry Disease

Singapore, Oct. 30 -- US-based BioMarin Pharmaceutical Inc. has entered into an exclusive worldwide license agreement with South Korea-based GC Biopharma Corp. and Hanmi Pharm Co., to develop and comm... Read More


Japan's GHIT invests $6.8 M in product development for Malaria, NTDs and Ebola

Singapore, Oct. 30 -- Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.06 billion ($6.8 million) in nine R&D projects for the develop... Read More


Australia's Firebrick Pharma announces launch of Nasodine(R) Sinus Rinse in Singapore

Singapore, Oct. 30 -- Australia-based Firebrick Pharma has announced the launch of its third product in the Nasodine range: Nasodine(R) Sinus Rinse. The product recently completed production and comme... Read More